Landscape of tumor-infiltrating T cell repertoire of human cancers

Nature Genetics

Volumn 48, Issue 7, 2016, Pages 725-732

  Li, Bo ^a,b   Li, Taiwen ^a,c   Pignon, Jean Christophe ^d   Wang, Binbin ^e   Wang, Jinzeng ^e   Shukla, Sachet A ^a   Dou, Ruoxu ^f   Chen, Qianming ^c   Hodi, F Stephen ^g   Choueiri, Toni K ^a   Wu, Catherine ^a   Hacohen, Nir ^h   Signoretti, Sabina ^d   Liu, Jun S ^b   Liu, X Shirley ^a,b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HARVARD UNIVERSITY   (United States)

^c SICHUAN UNIVERSITY   (China)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e TONGJI UNIVERSITY   (China)

^f SUN YAT SEN UNIVERSITY   (China)

^g HARVARD MEDICAL SCHOOL   (United States)

^h MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; COMPLEMENTARITY DETERMINING REGION; HLA ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR; PRAME PROTEIN, HUMAN; TUMOR ANTIGEN; TUMOR PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; BILE DUCT CARCINOMA; BRAIN CANCER; CANCER IMMUNOTHERAPY; COMPLEMENTARITY DETERMINING REGION; COMPLEMENTARITY DETERMINING REGION 3; HLA TYPING; HUMAN; HUMAN CELL; IMMUNOGENICITY; KIDNEY CANCER; MULTIPLE CANCER; MUTATIONAL LOAD; NEOPLASM; PRIORITY JOURNAL; PROTEIN BINDING; RNA SEQUENCE; SOMATIC MUTATION; TESTIS CANCER; TUMOR ASSOCIATED LEUKOCYTE; TUMOR INFILTRATING T LYMPHOCYTE; GENETICS; HIGH THROUGHPUT SEQUENCING; IMMUNOLOGY; METABOLISM; MUTATION; PROCEDURES; T LYMPHOCYTE SUBPOPULATION;

ANTIGENS, NEOPLASM; COMPLEMENTARITY DETERMINING REGIONS; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HLA ANTIGENS; HUMANS; LYMPHOCYTES, TUMOR-INFILTRATING; MUTATION; NEOPLASM PROTEINS; NEOPLASMS; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; T-LYMPHOCYTE SUBSETS;

EID: 84973137929     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng.3581     Document Type: Article

References (45)

1. Alt, F. W. et al. VDJ recombination. Immunol. Today 13, 306-314 (1992).
2. Davis, M. M. & Bjorkman, P. J. T-cell antigen receptor genes and T-cell recognition. Nature 334, 395-402 (1988).
3. Warren, R. L. et al. Exhaustive T-cell repertoire sequencing of human peripheral blood samples reveals signatures of antigen selection and a directly measured repertoire size of at least 1 million clonotypes. Genome Res. 21, 790-797 (2011).
4. Robins, H. S. et al. Comprehensive assessment of T-cell receptor-chain diversity in T cells. Blood 114, 4099-4107 (2009).
5. Rosenberg, S. A., Restifo, N. P., Yang, J. C., Morgan, R. A. & Dudley, M. E. Adoptive cell transfer: a clinical path to effective cancer immunotherapy. Nat. Rev. Cancer 8, 299-308 (2008).
6. Sharma, P., Wagner, K., Wolchok, J. D. & Allison, J. P. Novel cancer immunotherapy agents with survival benefit: recent successes and next steps. Nat. Rev. Cancer 11, 805-812 (2011).
7. Pardoll, D. M. The blockade of immune checkpoints in cancer immunotherapy. Nat. Rev. Cancer 12, 252-264 (2012).
8. Savage, P. A. et al. Recognition of a ubiquitous self antigen by prostate cancer-infiltrating CD8+ T lymphocytes. Science 319, 215-220 (2008).
9. Obenaus, M. et al. Identification of human T-cell receptors with optimal affinity to cancer antigens using antigen-negative humanized mice. Nat. Biotechnol. 33, 402-407 (2015).
10. Tumeh, P. C. et al. PD-1 blockade induces responses by inhibiting adaptive immune resistance. Nature 515, 568-571 (2014).
11. Twyman-Saint Victor, C. et al. Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer. Nature 520, 373-377 (2015).
12. Blachly, J. S. et al. Immunoglobulin transcript sequence and somatic hypermutation computation from unselected RNA-seq reads in chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. USA 112, 4322-4327 (2015).
13. Brown, S. D., Raeburn, L. A. & Holt, R. A. Profiling tissue-resident T cell repertoires by RNA sequencing. Genome Med. 7, 125 (2015).
14. Bolotin, D. A. et al. MiTCR: software for T-cell receptor sequencing data analysis. Nat. Methods 10, 813-814 (2013).
15. Grabherr, M. G. et al. Full-length transcriptome assembly from RNA-seq data without a reference genome. Nat. Biotechnol. 29, 644-652 (2011).
16. Warren, R. L., Nelson, B. H. & Holt, R. A. Profiling model T-cell metagenomes with short reads. Bioinformatics 25, 458-464 (2009).
17. Freeman, J. D., Warren, R. L., Webb, J. R., Nelson, B. H. & Holt, R. A. Profiling the T-cell receptor-chain repertoire by massively parallel sequencing. Genome Res. 19, 1817-1824 (2009).
18. van Heijst, J. W. et al. Quantitative assessment of T cell repertoire recovery after hematopoietic stem cell transplantation. Nat. Med. 19, 372-377 (2013).
19. Rooney, M. S., Shukla, S. A., Wu, C. J., Getz, G. & Hacohen, N. Molecular and genetic properties of tumors associated with local immune cytolytic activity. Cell 160, 48-61 (2015).
20. Chien, Y. H. & Hampl, J. Antigen-recognition properties of murine T cells. Springer Semin. Immunopathol. 22, 239-250 (2000).
21. Crooks, G. E., Hon, G., Chandonia, J. M. & Brenner, S. E. WebLogo: a sequence logo generator. Genome Res. 14, 1188-1190 (2004).
22. Dean, J. et al. Annotation of pseudogenic gene segments by massively parallel sequencing of rearranged lymphocyte receptor loci. Genome Med. 7, 123 (2015).
23. Rock, E. P., Sibbald, P. R., Davis, M. M. & Chien, Y. H. CDR3 length in antigen-specific immune receptors. J. Exp. Med. 179, 323-328 (1994).
24. Venturi, V., Price, D. A., Douek, D. C. & Davenport, M. P. The molecular basis for public T-cell responses? Nat. Rev. Immunol. 8, 231-238 (2008).
25. Chowell, D. et al. TCR contact residue hydrophobicity is a hallmark of immunogenic CD8+ T cell epitopes. Proc. Natl. Acad. Sci. USA 112, E1754-E1762 (2015).
26. Schuurs, A. H. & Verheul, H. A. Effects of gender and sex steroids on the immune response. J. Steroid Biochem. 35, 157-172 (1990).
27. Shukla, S. A. et al. Comprehensive analysis of cancer-associated somatic mutations in class I HLA genes. Nat. Biotechnol. 33, 1152-1158 (2015).
28. He, C. et al. Genome-wide detection of testis-and testicular cancer-specific alternative splicing. Carcinogenesis 28, 2484-2490 (2007).
29. Simpson, A. J., Caballero, O. L., Jungbluth, A., Chen, Y. T. & Old, L. J. Cancer/testis antigens, gametogenesis and cancer. Nat. Rev. Cancer 5, 615-625 (2005).
30. Caballero, O. L. & Chen, Y. T. Cancer/testis (CT) antigens: potential targets for immunotherapy. Cancer Sci. 100, 2014-2021 (2009).
31. Drake, C. G., Lipson, E. J. & Brahmer, J. R. Breathing new life into immunotherapy: review of melanoma, lung and kidney cancer. Nat. Rev. Clin. Oncol. 11, 24-37 (2014).
32. Silina, K. et al. Sperm-associated antigens as targets for cancer immunotherapy: expression pattern and humoral immune response in cancer patients. J. Immunother. 34, 28-44 (2011).
33. Andreatta, M., Schafer-Nielsen, C., Lund, O., Buus, S. & Nielsen, M. NNAlign: a web-based prediction method allowing non-expert end-user discovery of sequence motifs in quantitative peptide data. PLoS One 6, e26781 (2011).
34. Dunn, G. P., Bruce, A. T., Ikeda, H., Old, L. J. & Schreiber, R. D. Cancer immunoediting: from immunosurveillance to tumor escape. Nat. Immunol. 3, 991-998 (2002).
35. Andreatta, M. & Nielsen, M. Gapped sequence alignment using artificial neural networks: application to the MHC class I system. Bioinformatics 32, 511-517 (2016).
36. Nielsen, M., Lundegaard, C. & Lund, O. Prediction of MHC class II binding affinity using SMM-align, a novel stabilization matrix alignment method. BMC Bioinformatics 8, 238 (2007).
37. Grupp, S. A. et al. Chimeric antigen receptor-modified T cells for acute lymphoid leukemia. N. Engl. J. Med. 368, 1509-1518 (2013).
38. Porter, D. L., Levine, B. L., Kalos, M., Bagg, A. & June, C. H. Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia. N. Engl. J. Med. 365, 725-733 (2011).
39. Cancer Genome Atlas Research Network. Comprehensive molecular portraits of human breast tumours. Nature 490, 61-70 (2012).
40. Li, B. & Li, J. Z. A general framework for analyzing tumor subclonality using SNP array and DNA sequencing data. Genome Biol. 15, 473 (2014).
41. Wang, K. et al. MapSplice: accurate mapping of RNA-seq reads for splice junction discovery. Nucleic Acids Res. 38, e178 (2010).
42. Lefranc, M. P. IMGT, the International ImMunoGeneTics Information System. Cold Spring Harb. Protoc. 2011, 595-603 (2011).
43. Del Monte, U. Does the cell number 10(9) still really fit one gram of tumor tissue? Cell Cycle 8, 505-506 (2009).
44. Emerson, R. O. et al. High-throughput sequencing of T-cell receptors reveals a homogeneous repertoire of tumour-infiltrating lymphocytes in ovarian cancer. J. Pathol. 231, 433-440 (2013).
45. R Development Core Team. R: A Language and Environment for Statistical Computing (R Foundation for Statistical Computing, 2014).